6-(1-methylindazol-6-yl)-2-N-[2-[2-(trifluoromethyl)-1H-imidazol-5-yl]propan-2-yl]-1,3,5-triazine-2,4-diamine
C18H18F3N9 — CID 171803198
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(1-methylindazol-6-yl)-2-N-[2-[2-(trifluoromethyl)-1H-imidazol-5-yl]propan-2-yl]-1,3,5-triazine-2,4-diamine
6-(1-methylindazol-6-yl)-2-N-[2-[2-(trifluoromethyl)-1H-imidazol-5-yl]propan-2-yl]-1,3,5-triazine-2,4-diamine (PubChem CID 171803198) has the molecular formula C18H18F3N9 and a molecular weight of 417.40 g/mol. Its IUPAC name is 6-(1-methylindazol-6-yl)-2-N-[2-[2-(trifluoromethyl)-1H-imidazol-5-yl]propan-2-yl]-1,3,5-triazine-2,4-diamine.
Molecular Properties
| Compound Name | 6-(1-methylindazol-6-yl)-2-N-[2-[2-(trifluoromethyl)-1H-imidazol-5-yl]propan-2-yl]-1,3,5-triazine-2,4-diamine |
|---|---|
| PubChem CID | 171803198 |
| Molecular Formula | C18H18F3N9 |
| Molecular Weight | 417.40 g/mol |
| Exact Mass | 417.16 |
| IUPAC Name | 6-(1-methylindazol-6-yl)-2-N-[2-[2-(trifluoromethyl)-1H-imidazol-5-yl]propan-2-yl]-1,3,5-triazine-2,4-diamine |
| SMILES | Cn1ncc2ccc(-c3nc(N)nc(NC(C)(C)c4cnc(C(F)(F)F)[nH]4)n3)cc21 |
| InChI | InChI=1S/C18H18F3N9/c1-17(2,12-8-23-14(25-12)18(19,20)21)29-16-27-13(26-15(22)28-16)9-4-5-10-7-24-30(3)11(10)6-9/h4-8H,1-3H3,(H,23,25)(H3,22,26,27,28,29) |
| InChIKey | NJSSOPPDBLSEPC-UHFFFAOYSA-N |
| XLogP | 3.10 |
| TPSA | 123.22 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 417.40 |
| LogP ≤ 5 | 3.10 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171803198 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.